Am J Perinatol 1987; 4(2): 102-105
DOI: 10.1055/s-2007-999749
ORIGINAL ARTICLE

© 1987 by Thieme Medical Publishers, Inc.

Urinary 19-Nor-Deoxycorticosterone and Deoxycorticosterone in Hypertensive Disease of Pregnancy

Dinesh M. Shah1 , Celso E. Gomez-Sanchez2 , Robert A. Knuppel2 , William K. Vaughn1
  • 1Department of Obstetrics and Gynecology, University of South Florida, Tampa, Florida
  • 2Departments of Obstetrics and Gynecology and Internal Medicine, University of South Florida College of Medicine and The James A. Haley Veterans Hospital, Tampa, Florida
Further Information

Publication History

Publication Date:
04 March 2008 (online)

ABSTRACT

Normal pregnancy and pre-eclampsia are associated with water and sodium retention. Therefore various mineralocorticoids have been evaluated in normal and abnormal pregnancies. This study reports the urinary free 19-nor-deoxycorticosterone (19-nor-DOC) and deoxycorticosterone (DOC) levels in normal pregnancy and in patients with pregnancy-induced hypertension. Levels of 19-nor-DOC and DOC were not significantly different between normal patients in the third trimester and women with pregnancy-induced hypertension at a comparable gestational age. The urinary excretion of 19-nor-DOC in pregnancy was noted to be significantly lower than that previously reported in normal male volunteers. There was a positive correlation between 19-nor-DOC excretion and increasing gestational age. These data are compatible with the view that 19-nor-DOC may not play a role in pregnancy-induced hypertension. However, a larger study of primigravid women, with and without, pre-eclampsia is needed to confirm this finding.

    >